Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes
Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), David Hartley(Cincinnati Children's Hospital Medical Center), Baheyeldin Salem(Baylor College of Medicine), Kathleen Magee(Texas Children's Hospital), Leslie Lehmann(Harvard University), Kathryn Leung(Emory University), Sonata Jodele(Cincinnati Children's Hospital Medical Center), Seth J. Rotz(Cleveland Clinic), Loretta Parker(University of Oklahoma Medical Center), John Huber(Cincinnati Children's Hospital Medical Center), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Wayne H. Liang(Emory University), Megan Sampson(Akron Children's Hospital), Alan Bidgoli(Medical University of South Carolina), Nandita Khera(Mayo Clinic in Florida), Eleanor Cook(Cincinnati Children's Hospital Medical Center), Malika Kapadia(Harvard University), Nancy M. Daraiseh(Cincinnati Children's Hospital Medical Center), Taylor Fitch(University of Cincinnati Medical Center), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Javier Díaz(Nemours Children's Health System), Adam Nelson(Cincinnati Children's Hospital Medical Center), Jeffery J. Auletta(Nationwide Children's Hospital), Kathy Demmel(University of Cincinnati Medical Center), Miki Nishitani(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Anna M. DeSalvo(National Marrow Donor Program), Steffani Maier(Cincinnati Children's Hospital Medical Center), Priscila Badia(Cincinnati Children's Hospital Medical Center), Alana J. Snyder(Cincinnati Children's Hospital Medical Center), John Craddock(Children's Cancer Center), Georgia Kent(Cincinnati Children's Hospital Medical Center), Dónal O'Mathúna(The Ohio State University), Mark Juckett(UW Health University Hospital), Preston Epling(Cleveland Clinic), Ahna L. H. Pai(University of Cincinnati Medical Center)
Cited by 4
Related Papers
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Rural Health Disparities, Population Health, and Rural Culture
|American Journal of Public Health|2004|769
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577